The PI3K/Akt pathway: a target for curcumin's therapeutic effects

被引:0
|
作者
Aliyari, Mahdieh [1 ]
Ghoflchi, Sahar [1 ]
Hashemy, Seyed Isaac [1 ]
Hashemi, Seyedeh Fatemeh [2 ]
Reihani, Amirali [2 ]
Hosseini, Hossein [1 ,3 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Clin Biochem, Mashhad, Iran
[2] Mashhad Univ Med Sci, Student Res Comm, Fac Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Iran
关键词
Curcuma longa; Phosphoinositide; 3-kinase; Protein kinase B; Curcumin; Metabolic disease; Neurodegenerative disease; Kidney disorder; EPITHELIAL-MESENCHYMAL TRANSITION; FATTY LIVER-DISEASE; SIGNALING PATHWAY; ANTIINFLAMMATORY PROPERTIES; OXIDATIVE STRESS; NATURAL-PRODUCTS; PROTEIN-KINASE; HIGH GLUCOSE; INHIBITION; INJURY;
D O I
10.1007/s40200-025-01563-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe purpose of this review study is to investigate the effect of curcumin on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in various diseases. Curcumin, the main compound found in turmeric, has attracted a lot of attention for its diverse pharmacological properties. These properties have increased the therapeutic potential of curcumin in chronic diseases such as cardiovascular disease, Type 2 diabetes, obesity, non-alcoholic fatty liver disease, kidney disease, and neurodegenerative diseases. One of the main mechanisms of the effect of curcumin on health is its ability to modulate the PI3K/Akt signaling pathway. This pathway plays an important role in regulating vital cellular processes such as growth, cell survival, metabolism, and apoptosis. Disruption of the PI3K/Akt signaling pathway is associated with the incidence of several diseases.MethodsElectronic databases including PubMed, Google Scholar, and Scopus were searched with the keywords "phosphoinositide 3-kinase" AND "protein kinase B "AND "curcumin" in the title/abstract. Also, following keywords "non-alcoholic fatty liver disease" AND "diabetes" AND "obesity" AND "kidney disease" and "neurodegenerative diseases" was searched in the whole text.ResultsResearch indicates that curcumin offers potential benefits for several health conditions. Studies have shown it can help regulate blood sugar, reduce inflammation, and protect the heart, kidneys, and brain.ConclusionThis protective effect is partially achieved by regulating the PI3K-Akt survival pathway, which helps improve metabolic disorders and oxidative stress. By examining how curcumin affects this vital cell pathway, researchers can discover new treatment strategies for a range of diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
    Guo, Ningning
    Wang, Xin
    Xu, Muran
    Bai, Jie
    Yu, Hao
    Zhang, Le
    PHARMACOLOGICAL RESEARCH, 2024, 206
  • [42] OLFML3 suppresses trophoblast apoptosis via the PI3K/AKT pathway: A possible therapeutic target in preeclampsia
    Chen, Haiying
    Li, Ruiping
    Bian, Jiangyujing
    Li, Xiaoqing
    Su, Cunjing
    Wang, Yang
    Zhang, Hongping
    Zheng, Jianqiong
    Wang, Yeping
    Zhang, Hong
    PLACENTA, 2024, 147 : 1 - 11
  • [43] Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
    Ching, Christina Barbara
    Hansel, Donna Elizabeth
    LABORATORY INVESTIGATION, 2010, 90 (10) : 1406 - 1414
  • [44] The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
    Cheaib, Bianca
    Auguste, Aurelie
    Leary, Alexandra
    CHINESE JOURNAL OF CANCER, 2015, 34 (01) : 4 - 16
  • [45] mTOR/PI3k/Akt SIGNALING PATHWAY IN TUMOR ANGIOGENESIS AND THERAPEUTIC TARGETING
    Mabeta, Peace
    Davis, Paul F.
    Pepper, Michael S.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6042 - 6042
  • [46] eIF6: a promising therapeutic target for gastric carcinoma via PI3K/AKT pathway modulation
    Hou, Shuang
    Tang, Hao
    Dong, Zhikun
    Zhou, Wence
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [47] The PI3K-AKT pathway - a therapeutic target in melanoma brain metastases?
    Niessner, H.
    Schmitz, J.
    Schmid, A.
    Sinnberg, T.
    Tabatabai, G.
    Weide, B.
    Garbe, C.
    Quintanilla-Fend, L.
    Mai, M.
    Beissert, S.
    Kulms, D.
    Schackert, G.
    Muders, M.
    Meinhardt, M.
    Baretton, G.
    Pichler, B.
    Westphal, D.
    Meier, F.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E35 - E35
  • [48] Effects of small molecule inhibitors in the PI3K/AKT pathway on glioblastoma
    Hoernschemeyer, J.
    Lange, F.
    Reichart, G.
    Linnebacher, M.
    Kirschstein, T.
    Koehling, R.
    ACTA PHYSIOLOGICA, 2019, 227
  • [49] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [50] EHLJ7 exerts therapeutic effects on colorectal cancer via PI3K/AKT pathway
    Chai, Changwei
    Zhang, Yixiang
    Zhou, Ya
    Zhang, Haijing
    Wu, Lianqiu
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 470 - 471